# OnCo record xzp-3287 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/xzp-3287/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "xzp-3287" ;
  schema:name "XZP-3287"@en ;
  schema:description "XZP-3287 is an experimental small-molecule drug from Sihuan Pharmaceutical in phase 3 trials for HR-positive / HER2-negative breast cancer, with its target not yet stated publicly."@en ;
  schema:url <https://onco.cc/drugs/xzp-3287/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=XZP-3287>, <https://www.xuanzhubio.com> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "small molecule" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:companies <https://onco.cc/companies/xuanzhu-biopharmaceutical/> ;
  onco:trials <https://onco.cc/trials/nct05077449/>, <https://onco.cc/trials/nct04539496/>, <https://onco.cc/trials/nct05257395/> .